Source: High Yields
  • Sugarbud Craft Growers Corp. (SUGR) has amended the terms of its public offering of convertible debenture units
  • Sugarbud has reduced the conversion price of the convertible debentures from $1.39 to $1.29 per common share
  • Each debenture unit will consist of one 12.0 per cent secured convertible debenture and 775 common share purchase warrants
  • The company has also increased the size of the offering to up to $3,000,000 in gross proceeds
  • Sugarbud is a craft cannabis company focused on the cultivation and production of cannabis products
  • Sugarbud Craft Growers Corp. (SUGR) opened trading at C$1.29 per share

Sugarbud Craft Growers Corp. (SUGR) has amended the terms of its recently announced public offering of convertible debenture units.

Sugarbud has reduced the conversion price of the convertible debentures from $1.39 to $1.29 per common share and lowered the exercise price of the share purchase warrants from $1.39 to $1.29 per warrant. 

Each debenture unit will consist of one 12.0 per cent secured convertible debenture and 775 common share purchase warrants.

The company has also increased the size of the offering to up to $3,000,000 in gross proceeds.

Each warrant will entitle the holder to purchase one common share for a period of 5 years following the closing of the offering.

Debenture holders may elect to exchange their debentures for 15.0 per cent non-convertible secured notes.

The debentures will mature 5 years from the closing of the offering.

Sugarbud is a craft cannabis company focused on the cultivation and production of cannabis products.

Sugarbud Craft Growers Corp. (SUGR) opened trading at C$1.29 per share.

More From The Market Online

The 5-Minute Investor Podcast, Ep. 24: Cannabis reclassification plays

Listen to episode 24 of Stockhouse's 5-Minute Investor Podcast, featuring analysis on cannabis stocks Canopy Growth and Aurora.
Cannabis Report image of farmed cannabis plants

StockTalk | Cannabis Report: Quarterly report season heats up

Vertically-integrated producer of premium-grade cannabis products, Cannara Biotech Inc. reported gross cannabis revenues before excise taxes...
Cannabis Report across cannabis plants

StockTalk | Cannabis Report: Shake-ups

MediPharm Labs announced that chief executive officer, David Pidduck will step down from his role, effective January...

Buzz on the Bullboards: As Arctic tensions flare, investors eye three news‑making stocks

Global markets opened the week on edge as a fresh rift between Washington and key NATO...